Universal Beteiligungs und Servicegesellschaft mbH Has $18.13 Million Stake in Align Technology, Inc. $ALGN

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH trimmed its stake in Align by 7.0%, selling 8,672 shares and finishing the quarter with 115,531 shares (about 0.16%) valued at roughly $18.13 million.
• Align beat quarterly expectations — EPS $3.29 vs $2.99 consensus and revenue $1.05B vs $1.03B (revenue +5.3% YoY); the stock trades near $189.61 with a ~$13.6B market cap and a 12‑month range of $122–$208.30.
• Insider selling and analyst outlook: EVP John Morici sold 7,969 shares (reducing his holding ~49%), while analysts have issued upgrades and the consensus rating is a "Moderate Buy" with a ~$203.92 price target.

Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 7.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 115,531 shares of the medical equipment provider's stock after selling 8,672 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.16% of Align Technology worth $18,125,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of ALGN. Sentry Investment Management LLC boosted its holdings in Align Technology by 73.1% during the third quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider's stock valued at $25,000 after acquiring an additional 79 shares during the period. Steigerwald Gordon & Koch Inc. bought a new stake in Align Technology during the third quarter valued at about $26,000. Independence Bank of Kentucky boosted its holdings in Align Technology by 77.7% during the fourth quarter. Independence Bank of Kentucky now owns 183 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 80 shares during the period. Quent Capital LLC bought a new stake in Align Technology during the third quarter valued at about $30,000. Finally, TD Private Client Wealth LLC boosted its holdings in Align Technology by 135.6% during the third quarter. TD Private Client Wealth LLC now owns 238 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 137 shares during the period. 88.43% of the stock is currently owned by institutional investors.

Align Technology Stock Performance

NASDAQ ALGN opened at $189.61 on Friday. The firm has a 50-day simple moving average of $179.78 and a 200 day simple moving average of $162.64. Align Technology, Inc. has a twelve month low of $122.00 and a twelve month high of $208.30. The stock has a market cap of $13.58 billion, a PE ratio of 33.50, a PEG ratio of 2.07 and a beta of 1.81.

Align Technology (NASDAQ:ALGN - Get Free Report) last released its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.30. Align Technology had a net margin of 10.17% and a return on equity of 15.16%. The business had revenue of $1.05 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same quarter last year, the company earned $2.44 earnings per share. The firm's revenue was up 5.3% on a year-over-year basis. Research analysts forecast that Align Technology, Inc. will post 9.15 earnings per share for the current fiscal year.

Insider Buying and Selling at Align Technology

In related news, EVP John Morici sold 7,969 shares of the stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $189.31, for a total value of $1,508,611.39. Following the completion of the sale, the executive vice president owned 8,237 shares in the company, valued at approximately $1,559,346.47. This trade represents a 49.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.75% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on ALGN shares. Wall Street Zen upgraded shares of Align Technology from a "buy" rating to a "strong-buy" rating in a report on Saturday, March 7th. Barclays upgraded shares of Align Technology from an "equal weight" rating to an "overweight" rating and set a $200.00 price target for the company in a report on Tuesday, March 17th. Morgan Stanley upped their price target on shares of Align Technology from $169.00 to $188.00 and gave the company an "equal weight" rating in a report on Friday. UBS Group upped their price target on shares of Align Technology from $175.00 to $185.00 and gave the company a "neutral" rating in a report on Thursday, February 5th. Finally, Leerink Partners upped their price target on shares of Align Technology from $210.00 to $225.00 and gave the company an "outperform" rating in a report on Thursday, February 5th. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $203.92.

Align Technology Profile

Align Technology, Inc NASDAQ: ALGN pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.